NT Biopharmaceuticals Jiangsu

NT Biopharmaceuticals Jiangsu is a pharmaceutical company based in Taizhou, China, serving as the primary manufacturing and research hub for China NT Pharma Group. The company specializes in the development and production of biologics and small molecule drugs, with a strong focus on therapeutic areas including oncology, hematology, and infectious diseases. Its state-of-the-art facilities in the China Medical City are built to GMP standards and support the production of the company's flagship products, such as recombinant human erythropoietin (rhEPO). By integrating R&D with large-scale manufacturing, NT Biopharmaceuticals Jiangsu supports the broader group's mission to provide affordable, high-quality medical solutions to the Chinese market. The company plays a critical role in the parent group's vertically integrated business model, spanning from drug discovery to commercial distribution.